Linda Howes Graham
Psychiatry · Wilmington, NCNPI 1790706554
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,237 and has fallen 83.8% since, to $201 in 2023.
Across 156 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$442
- Eisai Inc.$340
- Otsuka America Pharmaceutical, Inc.$296
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$230
- Vanda Pharmaceuticals Inc.$210
- Lundbeck LLC$165
- plus $1K from 14 others
What the payments were for
- Food & beverage$2,715100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 36 | $442 |
| Eisai Inc. | 31 | $340 |
| Otsuka America Pharmaceutical, Inc. | 13 | $296 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $230 |
| Vanda Pharmaceuticals Inc. | 11 | $210 |
| Lundbeck LLC | 8 | $165 |
| Neurocrine Biosciences, Inc. | 3 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $147 |
| Validus Pharmaceuticals LLC | 1 | $136 |
| Sunovion Pharmaceuticals Inc. | 5 | $105 |
| Corium, LLC | 4 | $98 |
| Neos Therapeutics, LP | 5 | $87 |
| Johnson & Johnson | 4 | $63 |
| Avanir Pharmaceuticals, Inc. | 3 | $47 |
| Jazz Pharmaceuticals Inc. | 3 | $46 |
| Bausch Health US, LLC | 2 | $39 |
| Tris Pharma Inc | 2 | $35 |
| Merck | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Alkermes, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,715 in reported general payments places this provider in the 80th percentile of 1,108 psychiatry providers in North Carolina.
Other psychiatry in Wilmington
- Paul BuongiornoWilmington$208K
- Rano MathewWilmington$15K
- Craig ChepkeHuntersville$4.1M
- Mark ReynoldsDurham$3.2M
- James BarkerHickory$2.1M
- Brian FarahWinston Salem$605K
- Krishna TalluriMorrisville$591K
- Ramesh GihwalaGastonia$545K
- Keshavpal ReddyGreensboro$480K
- Robert MilletRaleigh$476K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.